This HTML5 document contains 73 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n16http://linked.opendata.cz/resource/drugbank/drug/DB03843/identifier/wikipedia/
n17http://linked.opendata.cz/resource/drugbank/drug/DB03843/identifier/pharmgkb/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n15http://linked.opendata.cz/resource/drugbank/drug/DB03843/identifier/pdb/
n18http://linked.opendata.cz/resource/drugbank/drug/DB03843/identifier/kegg-compound/
n23http://linked.opendata.cz/resource/mesh/concept/
n24http://linked.opendata.cz/resource/drugbank/company/
foafhttp://xmlns.com/foaf/0.1/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03843/identifier/pubchem-compound/
n10http://linked.opendata.cz/resource/drugbank/mixture/
n19http://linked.opendata.cz/resource/drugbank/drug/DB03843/identifier/kegg-drug/
n14http://linked.opendata.cz/resource/drugbank/drug/DB03843/identifier/pubchem-substance/
n9http://linked.opendata.cz/resource/drugbank/drug/DB03843/identifier/drugbank/
n13http://bio2rdf.org/drugbank:
n21http://linked.opendata.cz/resource/drugbank/drug/DB03843/identifier/iuphar/
n20http://linked.opendata.cz/resource/drugbank/drug/DB03843/identifier/guide-to-pharmacology/
admshttp://www.w3.org/ns/adms#
n25http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n22http://linked.opendata.cz/ontology/mesh/
n5http://linked.opendata.cz/ontology/drugbank/
n4http://www.drugs.com/cdi/
n6http://linked.opendata.cz/resource/drugbank/property/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03843/identifier/chebi/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB03843
rdf:type
n5:Drug
n5:description
A highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons. In solution, it has a wide range of uses: in the manufacture of resins and textiles, as a disinfectant, and as a laboratory fixative or preservative. Formaldehyde solution (formalin) is considered a hazardous compound, and its vapor toxic. (From Reynolds, Martindale The Extra Pharmacopoeia, 30th ed, p717)
n5:group
experimental
owl:sameAs
n13:DB03843 n25:DB03843
dcterms:title
Formaldehyde
adms:identifier
n8:16842 n9:DB03843 n11:712 n14:46505094 n15:FLH n16:Formaldehyde n17:PA449703 n18:C00067 n19:D00017 n20:4196 n21:4196
n5:packager
n24:271B47AE-363D-11E5-9242-09173F13E4C5 n24:271B47AF-363D-11E5-9242-09173F13E4C5 n24:271B47AD-363D-11E5-9242-09173F13E4C5 n24:271B47B2-363D-11E5-9242-09173F13E4C5 n24:271B47B3-363D-11E5-9242-09173F13E4C5 n24:271B47B0-363D-11E5-9242-09173F13E4C5 n24:271B47B1-363D-11E5-9242-09173F13E4C5 n24:271B47AB-363D-11E5-9242-09173F13E4C5 n24:271B47AC-363D-11E5-9242-09173F13E4C5
n5:synonym
Methanal Oxymethylene Methyl aldehyde Paraformaldehyde Paraform Oxomethylene Methylene oxide Oxomethane
n5:toxicity
Acute oral toxicity (LD50): 42 mg/kg [Mouse].
n5:mixture
n10:271B47AA-363D-11E5-9242-09173F13E4C5 n10:271B47A8-363D-11E5-9242-09173F13E4C5 n10:271B47A9-363D-11E5-9242-09173F13E4C5
n5:synthesisReference
Walter Hasselman, Jr., "Process for the preparation of phenol-urea-formaldehyde condensation products." U.S. Patent US4345061, issued August, 1926.
n22:hasConcept
n23:M0008753
foaf:page
n4:formaldehyde-solution.html
n5:IUPAC-Name
n6:271B47B8-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B47BE-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B47BD-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B47BA-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B47BB-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B47BC-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B47CD-363D-11E5-9242-09173F13E4C5 n6:271B47B6-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B47B4-363D-11E5-9242-09173F13E4C5 n6:271B47D0-363D-11E5-9242-09173F13E4C5 n6:271B47B7-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B47B5-363D-11E5-9242-09173F13E4C5
n5:pKa
n6:271B47D1-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B47C4-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B47C5-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B47BF-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B47C0-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B47C2-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B47C1-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B47C3-363D-11E5-9242-09173F13E4C5
n5:casRegistryNumber
50-00-0
n5:category
n5:Bioavailability
n6:271B47C9-363D-11E5-9242-09173F13E4C5
n5:Boiling-Point
n6:271B47CF-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B47CB-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B47CC-363D-11E5-9242-09173F13E4C5
n5:Melting-Point
n6:271B47CE-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B47C8-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B47C7-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B47CA-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B47B9-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B47C6-363D-11E5-9242-09173F13E4C5